These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
328 related items for PubMed ID: 15880596
1. An international cohort study of cancer in systemic lupus erythematosus. Bernatsky S, Boivin JF, Joseph L, Rajan R, Zoma A, Manzi S, Ginzler E, Urowitz M, Gladman D, Fortin PR, Petri M, Edworthy S, Barr S, Gordon C, Bae SC, Sibley J, Isenberg D, Rahman A, Aranow C, Dooley MA, Steinsson K, Nived O, Sturfelt G, Alarcón G, Senécal JL, Zummer M, Hanly J, Ensworth S, Pope J, El-Gabalawy H, McCarthy T, St Pierre Y, Ramsey-Goldman R, Clarke A. Arthritis Rheum; 2005 May; 52(5):1481-90. PubMed ID: 15880596 [Abstract] [Full Text] [Related]
2. Risk of malignancy in women with systemic lupus erythematosus. Sweeney DM, Manzi S, Janosky J, Selvaggi KJ, Ferri W, Medsger TA, Ramsey-Goldman R. J Rheumatol; 1995 Aug; 22(8):1478-82. PubMed ID: 7473469 [Abstract] [Full Text] [Related]
3. High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort. Dreyer L, Faurschou M, Mogensen M, Jacobsen S. Arthritis Rheum; 2011 Oct; 63(10):3032-7. PubMed ID: 21953088 [Abstract] [Full Text] [Related]
4. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, Rapiti E, Levi F, Jundt G, Fisch T, Bordoni A, De Weck D, Franceschi S, Swiss HIV Cohort. J Natl Cancer Inst; 2005 Mar 16; 97(6):425-32. PubMed ID: 15770006 [Abstract] [Full Text] [Related]
5. Increased risk of malignancy in patients with systemic lupus erythematosus. Ramsey-Goldman R, Mattai SA, Schilling E, Chiu YL, Alo CJ, Howe HL, Manzi S. J Investig Med; 1998 Jun 16; 46(5):217-22. PubMed ID: 9676054 [Abstract] [Full Text] [Related]
6. Hodgkin's lymphoma in systemic lupus erythematosus. Bernatsky S, Ramsey-Goldman R, Isenberg D, Rahman A, Dooley MA, Sibley J, Boivin JF, Joseph L, Armitage J, Zoma A, Clarke A. Rheumatology (Oxford); 2007 May 16; 46(5):830-2. PubMed ID: 17255135 [Abstract] [Full Text] [Related]
7. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts. Huang KP, Weinstock MA, Clarke CA, McMillan A, Hoppe RT, Kim YH. Arch Dermatol; 2007 Jan 16; 143(1):45-50. PubMed ID: 17224541 [Abstract] [Full Text] [Related]
8. Hormonal exposures and breast cancer in a sample of women with systemic lupus erythematosus. Bernatsky S, Clarke A, Ramsey-Goldman R, Joseph L, Boivin JF, Rajan R, Moore AD, Leung MH, Allen A, Gordon C. Rheumatology (Oxford); 2004 Sep 16; 43(9):1178-81. PubMed ID: 15226516 [Abstract] [Full Text] [Related]
9. Annual incidence and standardized incidence ratio of cerebrovascular accidents in patients with systemic lupus erythematosus. Mok CC, Ho LY, To CH. Scand J Rheumatol; 2009 Sep 16; 38(5):362-8. PubMed ID: 19296403 [Abstract] [Full Text] [Related]
10. [The occurrence of malignancies in a Hungarian lupus population]. Tarr T, Szekanecz E, Zeher M, Szegedi G, Kiss E. Orv Hetil; 2006 Nov 19; 147(46):2229-33. PubMed ID: 17396395 [Abstract] [Full Text] [Related]
11. The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort study. Bernatsky S, Joseph L, Boivin JF, Gordon C, Urowitz M, Gladman D, Fortin PR, Ginzler E, Bae SC, Barr S, Edworthy S, Isenberg D, Rahman A, Petri M, Alarcón GS, Aranow C, Dooley MA, Rajan R, Sénécal JL, Zummer M, Manzi S, Ramsey-Goldman R, Clarke AE. Ann Rheum Dis; 2008 Jan 19; 67(1):74-9. PubMed ID: 17545189 [Abstract] [Full Text] [Related]
12. Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate. Buchbinder R, Barber M, Heuzenroeder L, Wluka AE, Giles G, Hall S, Harkness A, Lewis D, Littlejohn G, Miller MH, Ryan PF, Jolley D. Arthritis Rheum; 2008 Jun 15; 59(6):794-9. PubMed ID: 18512713 [Abstract] [Full Text] [Related]
13. The association between malignant melanoma and noncutaneous malignancies. Wu YH, Kim GH, Wagner JD, Hood AF, Chuang TY. Int J Dermatol; 2006 May 15; 45(5):529-34. PubMed ID: 16700785 [Abstract] [Full Text] [Related]
14. Incidence of cancer in a cohort of patients with primary Sjogren's syndrome. Lazarus MN, Robinson D, Mak V, Møller H, Isenberg DA. Rheumatology (Oxford); 2006 Aug 15; 45(8):1012-5. PubMed ID: 16490754 [Abstract] [Full Text] [Related]
15. Incidence of cancer among patients with knee implants in Sweden, 1980-1994. Fryzek JP, Ye W, Signorello LB, Lipworth L, Blot WJ, McLaughlin JK, Nyren O. Cancer; 2002 Jun 01; 94(11):3057-62. PubMed ID: 12115397 [Abstract] [Full Text] [Related]
16. Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study. Schaapveld M, Visser O, Louwman MJ, de Vries EG, Willemse PH, Otter R, van der Graaf WT, Coebergh JW, van Leeuwen FE. J Clin Oncol; 2008 Mar 10; 26(8):1239-46. PubMed ID: 18323547 [Abstract] [Full Text] [Related]